Low sodium krill oil opens the door to approved blood pressure health claim in Europe
Dietary supplement companies looking for an edge in the European market can now make a blood pressure-related health claim on their labels simply by incorporating Enzymotec’s unique low sodium K•REAL® krill oil into their products.
K•REAL® – Low Sodium Krill Oil
K•REAL® is the only pure krill oil that meets the criteria needed to make a ‘Low Sodium’ claim under the EU’s Nutrition & Health Claims Regulation. In turn, this means supplements containing K•REAL® can also carry the health claim: “Reducing consumption of sodium contributes to the maintenance of normal blood pressure”.
Dr Ariel Katz, President & CEO of Enzymotec, said: “This benefit is exclusive to K•REAL®. No other krill oil offers sodium levels as low as ours does, creating an opportunity for dietary supplement manufacturers and marketers to give their products a unique selling point that will be compelling to their consumers.”
High sodium intake is associated with higher blood pressure, which is the leading cause of cardiovascular disease, particularly strokes and heart attacks. Cutting back on sodium in the diet is a simple way to reduce the risk of heart
disease. Enzymotec will showcase the low sodium benefits of K•REAL® on Stand 7F59 at the forthcoming Food Ingredients Europe exhibition, which takes place in Paris from 1-3 December 2015.
K•REAL® is produced using Enzymotec’s proprietary MSO® (Multi-Stage Oil) extraction process. As well as resulting in lower sodium levels than other krill oils, this guarantees a high quality oil with superior organoleptic properties compared with other commercially available products.
K•REAL® krill oil offers better absorption of Omega 3 by the body than fish oil. This results in enhanced bio-efficiency, because more Omega 3 reaches the red blood cells, where it can target organs such as the brain, heart and liver. With K•REAL® there are no fishy burps after consuming it, and it is produced from krill that are harvested sustainably by Enzymotec’s carefully chosen suppliers. Dr Katz added: “The Omega 3 supplements market is highly competitive and a tough space to operate in. But with its unique low sodium benefit, K•REAL® is an unbeatable choice of ingredient for manufacturers and brands seeking a powerful proposition that will ensure their products stand out on store shelves.”
For more information, please contact:
Kine Bjoralt, Ingredient Communications
Tel: +44 141 280 4141
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. Based in Israel, the company develops, manufactures and markets innovative bio-functional lipid ingredients, as well as final products, based on
sophisticated proprietary processes and technologies. For more information, visit www.enzymotec.com.